Clark William D 4
4 · Aldeyra Therapeutics, Inc. · Filed Apr 18, 2025
Insider Transaction Report
Form 4
Clark William D
Director
Transactions
- Award
Stock Option (Right to Buy)
2025-04-17+76,760→ 76,760 totalExercise: $2.19Exp: 2035-04-16→ Common Stock (76,760 underlying)
Footnotes (1)
- [F1]The stock option is exercisable in equal annual installments over three years of continuous service to the Issuer after April 17, 2025.